School of Medicine
Showing 151-160 of 367 Results
-
Felix Horns
Assistant Professor of Genetics
BioFelix Horns is an Assistant Professor of Genetics at Stanford University and a Core Investigator at Arc Institute. The Horns group works at the interface of synthetic biology and genomics to develop and apply technologies for monitoring and manipulating cells, with particular focus on the immune system and the brain.
Felix earned his B.A. in Biology from Amherst College and his Ph.D. in Biophysics working with Dr. Stephen Quake at Stanford, where he developed and used single-cell genomics, high-throughput sequencing, and computational analysis approaches to understand the origins of human antibody diversity and to discover principles of how brain circuits assemble during development. He then joined Dr. Michael Elowitz's lab at the California Institute of Technology where he combined synthetic biology and genomics approaches to develop RNA packaging, secretion, and delivery systems, which open new avenues for understanding and controlling cellular behaviors. -
Alexander Ioannidis
Assistant Professor (Research) of Genetics and of Biomedical Data Science
Adjunct Professor, Institute for Computational and Mathematical Engineering (ICME)BioDr. Ioannidis earned his Ph.D. from Stanford University in Computational and Mathematical Engineering together with an M.S. in Management Science and Engineering (Optimization). He graduated summa cum laude from Harvard University in Chemistry and Physics and earned an M.Phil at the University of Cambridge from the Department of Applied Math and Theoretical Physics in Computational Biology. His research focuses on the design of algorithms and application of computational methods for problems in precision health, genomics, clinical data science, and AI in healthcare.
-
Livnat Jerby
Assistant Professor of Genetics
Current Research and Scholarly InterestsCombining and advancing functional genomics, cell engineering, synthetic biology, AI, and basic immunology to uncover, decode, rewire, and develop mechanisms to selectively eliminate and reprogram disease-driving cells as a foundation for disease treatment and prevention.